Alternation of Non-alcoholic Fatty Liver Disease (NAFLD) and Cardiovascular Risks After Liftestyle Modification: A Ultrasound Attenuation Imaging-Based Study
Effectiveness of Lifestyle Modification Program in Reversal of Non-alcoholic Fatty Liver Disease (NAFLD) and Reduction of Cardiovascular Risks in Moderate Obesity: A Ultrasound Attenuation Imaging-Based Study
Sponsor: Chinese University of Hong Kong
Terminated
the patient recruitment was severely affected by COVID-19 pandemic
Other terminated trials from Chinese University of Hong Kong
Other Non-alcoholic Fatty Liver Disease trials with similar outcome
This NA trial investigates Non-alcoholic Fatty Liver Disease and is currently terminated or withdrawn. Chinese University of Hong Kong leads this study, which shows 9 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Mar 2024 — Jul 2024 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Sep 2023 — Mar 2024 [monthly]
Recruiting NA
-
Jun 2022 — Sep 2023 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
▶ Show 4 earlier versions
-
Feb 2021 — Jun 2022 [monthly]
Not Yet Recruiting NA
-
Jan 2021 — Feb 2021 [monthly]
Not Yet Recruiting NA
-
Aug 2020 — Jan 2021 [monthly]
Not Yet Recruiting NA
-
Jul 2020 — Aug 2020 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Chinese University of Hong Kong
For direct contact, visit the study record on ClinicalTrials.gov .